Complex drug interactions in an HIV-seropositive heart transplant recipient.
Complex drug interactions in an HIV-seropositive heart transplant recipient.
Turk Kardiyol Dern Ars. 2020 Mar;48(2):180-184
Authors: Sénéchal I, Châteauvert N, Gervais P, Voisine P, Dubois M, Sénéchal M
Abstract
Highly active antiretroviral therapy has led to greater life expectancy for human immun-deficiency virus (HIV)-positive patients. This was a report of 11 years of follow-up of an HIV-seropositive patient who underwent heart transplantation in 2006, with emphasis on the management challenges of complex drug interactions over time.
PMID: 32147653 [PubMed - in process]
Source: Turk Kardiyoloji Dernegi arsivi - Category: Cardiology Authors: Sénéchal I, Châteauvert N, Gervais P, Voisine P, Dubois M, Sénéchal M Tags: Turk Kardiyol Dern Ars Source Type: research
More News: Cardiology | Heart | Heart Transplant | Highly Active Antiretroviral Therapy | Transplant Surgery | Transplants